SIRT4 and cardiac hypertrophy: By raising ROS levels, Sirt4-mediated hypertrophic response was inhibited through the development, fibrosis, and cardiac dysfunction, pointing to a possible involvement for Sirt4 in pathological cardiac hypertrophy (Ramachandra et al., 2021).